Workflow
Autoimmune disease
icon
Search documents
X @The Wall Street Journal
Autoimmune disease rates sharply increase after age 50, with cases often unrecognized for years, according to a Mayo Clinic study https://t.co/LOtmn0BWVz ...
X @The Wall Street Journal
Autoimmune disease rates sharply increase after age 50, with cases often unrecognized for years, according to a Mayo Clinic study https://t.co/5basIag9Aw ...
Healing Beyond the Cure | Sarah Emily Bahari Binti Mohd Emil Azril Bahari | TEDxIMU
TEDx Talks· 2025-11-19 17:21
It all started with a headache. A headache that turned into pain in every part of my body. A pain that has stayed with me since I was 9 years old for every second of my life. I was always known as the girl who always missed school. Every time my friends would come and sleep over, they would joke that my room was built more like a pharmacy than anything else. For 11 years, I didn't know what was wrong with me. My disease remained undiagnosed. How do you fight something you can't see? How do you fight somethi ...
Kyverna Therapeutics (NasdaqGS:KYTX) 2025 Conference Transcript
2025-11-17 14:02
Summary of Kyverna Therapeutics Conference Call Company Overview - **Company**: Kyverna Therapeutics (NasdaqGS:KYTX) - **Focus**: Pioneering CAR T therapies for autoimmune diseases, specifically targeting stiff person syndrome and myasthenia gravis [2][3][4] Key Points and Arguments CAR T Therapy Development - Kyverna is advancing its unique CAR T construct, **KYV101**, designed for autoimmune diseases, emphasizing improved safety while maintaining potency and efficacy [2][3] - Over **100 patients** have been treated with KYV101, showing no high-grade CRS or ICANS, which de-risks the therapy for pivotal clinical studies [3] - The company aims to be the **first to launch CAR T therapies** for stiff person syndrome and myasthenia gravis, with FDA alignment on clinical pathways [3][9] Strategic Focus - The strategy includes a focus on **neuroimmunology** with KYV101 and a next-generation construct, **KYV102**, aimed at broadening patient access and reducing costs [4][10] - The company is targeting larger indications like **multiple sclerosis (MS)** and **rheumatoid arthritis (RA)**, which have significant unmet needs [5][10] Clinical Results - Early results from KYV101 show significant clinical reductions in symptoms for patients with stiff person syndrome and myasthenia gravis, with some patients achieving over **50-60%** improvement in the time 25-foot walk test [13][14] - Patients have been able to eliminate background immunosuppressants, indicating a transformative impact on their treatment [14][21] Market Opportunity - The market for stiff person syndrome is estimated to have **6,000 confirmed patients** in the U.S., with a significant portion being severely refractory to existing treatments [16][17] - For myasthenia gravis, up to **50%** of treated patients have inadequate symptom control, representing a substantial market opportunity [25][26] Financial Position - Kyverna is in a strong financial position with a cash runway extending into **2027**, supported by recent debt financing [31] Future Directions - The company is focused on advancing KYV101 for stiff person syndrome and myasthenia gravis, with plans to file for IND for KYV102 by the end of the year [28][31] - There is potential for expansion into additional indications as data matures [29] Additional Important Insights - The current treatment landscape for stiff person syndrome lacks approved therapies, highlighting the urgency and potential impact of KYV101 [11][12] - The economic burden of managing these autoimmune diseases is significant, with costs reaching **hundreds of thousands of dollars** annually, underscoring the health economic benefits of CAR T therapy [8][9] - The company emphasizes the **first-mover advantage** in the CAR T space for autoimmune diseases, which could set commercial pricing and market access standards [30][31]
Shining a light on invisible illness | Stephanie Young | TEDxAshburyCollege
TEDx Talks· 2025-08-26 15:32
There's a season of life we all go through when your friends start getting married, buying their first homes, landing promotions, and starting families. It's a stage of life that's full of celebrations and milestones and forward motion. It was during this stage of my life, as everyone around me was accelerating, that I felt like I was caught in a state of inertia.I was in a health crisis. I was watching the world move around me while I stayed still. It was during my mid20s after countless unexplained visits ...
Empathy: Believing Pain You Can't See | Harshita Kumari | TEDxYouth@TheShriramMillenniumSchoolNoida
TEDx Talks· 2025-08-14 15:33
Personal Experience & Disability Awareness - The speaker shares personal experiences with multiple sclerosis and related disorders, highlighting the challenges of living with an often invisible disability [1] - The speaker discusses the societal perception of disability, moving from pity and charity to empathy and understanding [1] - The speaker emphasizes the importance of empathy and small acts of kindness in making the world more livable for people with disabilities [1][2] Healthcare & Medical Diagnosis - The speaker recounts a decade-long journey of medical diagnoses, including multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and MOG antibody-associated disease [1] - The speaker describes the impact of these conditions on physical abilities, including walking, talking, and vision [1] - The speaker mentions undergoing chemotherapy as part of the treatment [1] Societal Barriers & Invisible Disabilities - The speaker describes the challenges of navigating societal barriers, such as using elevators designated for people with disabilities and facing disbelief or questioning [1] - The speaker highlights the emotional and physical exhaustion of constantly translating one's body and negotiating pain levels due to an invisible disability [1] - The speaker points out that the real barrier is not the physical one, but the silence, disbelief, and discomfort encountered from others [1]
X @Bloomberg
Bloomberg· 2025-08-11 05:55
Novartis succeeded in treating a form of autoimmune disease in late-stage studies, offering a boost for the Swiss drugmaker’s potential for treatments in the field https://t.co/LimHNRRlYA ...
Out of breath, but not out of fight | Tiffany Thompson | TEDxSherbrooke Street West
TEDx Talks· 2025-08-06 15:19
Health & Wellness Insights - The speaker was diagnosed with an autoimmune disease in 2021, resulting in 44% lung capacity [1] - Approximately 1 in 5 Canadians, nearly 8 million people, live with an autoimmune disease [2] - Narrative research indicates that two-thirds of Canadians adopted a new hobby after the pandemic started [12] Personal Development & Resilience - The speaker chose to engage in a high-intensity sport (tennis) despite physical limitations [1][8] - The speaker highlights the importance of starting despite limitations, choosing play over perfection, listening to the body, and finding a supportive community [16][17][18] - The speaker emphasizes that effort matters more than ease and that showing up imperfectly is better than quitting [15] Benefits of Hobbies & Activities - Hobbies can improve mental health by reducing stress and lifting mood [12] - Hobbies can boost physical health, leading to better sleep and stronger muscles [13] - Hobbies can improve social connection, especially during difficult times [13]